Ursodeoxycholic acid ameliorates hepatic lipid metabolism in LO2 cells by regulating the AKT/mTOR/SREBP-1 signaling pathway

Latest development in the synthesis of ursodeoxycholic acid (UDCA): a critical review

(2018) Fabio Tonin et al.   Beilstein Journal of Organic Chemistry

The Associations between Circulating Bile Acids and the Muscle Volume in Patients with Non-alcoholic Fatty Liver Disease (NAFLD)

(2017) Yoshinao Kobayashi et al.   INTERNAL MEDICINE

Acyl-CoA synthetase short-chain family member 2 (ACSS2) is regulated by SREBP-1 and plays a role in fatty acid synthesis in caprine mammary epithelial cells

(2017) Huifen Xu et al.   JOURNAL OF CELLULAR PHYSIOLOGY

Bile acids and their receptors during liver regeneration: “Dangerous protectors”

(2017) Grégory Merlen et al.   MOLECULAR ASPECTS OF MEDICINE

The role of bile acids in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis

(2017) Monica D. Chow et al.   MOLECULAR ASPECTS OF MEDICINE

Essential roles of bile acids and their nuclear receptors, FXR and PXR, in the cholestatic liver disease

(2016) Bumin Han et al.   Animal Cells and Systems

Luteolin Inhibits Proliferation and Induces Apoptosis of Human Placental Choriocarcinoma Cells by Blocking the PI3K/AKT Pathway and Regulating Sterol Regulatory Element Binding Protein Activity

(2016) W. Lim et al.   BIOLOGY OF REPRODUCTION

Swertiamarin ameliorates oleic acid induced lipid accumulation and oxidative stress by attenuating gluconeogenesis and lipogenesis in hepatic steatosis

(2016) Tushar P. Patel et al.   BIOMEDICINE & PHARMACOTHERAPY

Insulin Stimulates Goose Liver Cell Growth by Activating PI3K-AKT-mTOR Signal Pathway

(2016) Chunchun Han et al.   CELLULAR PHYSIOLOGY AND BIOCHEMISTRY

Bile acids and nonalcoholic fatty liver disease: Molecular insights and therapeutic perspectives

(2016) Juan P. Arab et al.   HEPATOLOGY

Clinical patterns of hepatocellular carcinoma in nonalcoholic fatty liver disease: A multicenter prospective study

(2016) Fabio Piscaglia et al.   HEPATOLOGY

Dihydromyricetin ameliorates oleic acid-induced lipid accumulation in L02 and HepG2 cells by inhibiting lipogenesis and oxidative stress

(2016) Caifeng Xie et al.   LIFE SCIENCES

Novel role for the CRTC2 in lipid homeostasis

(2016) Takashi Matsuzaka et al.   Journal of Diabetes Investigation

Fatty liver diseases, bile acids, and FXR

(2016) Yan Zhu et al.   Acta Pharmaceutica Sinica B

Oxidative stress, mitochondria damage and matrix metalloprotease activation in the pathogenesis of NAFLD

(2015) C. Berardo et al.   DIGESTIVE AND LIVER DISEASE

Bile acids and nonalcoholic fatty liver disease: An intriguing relationship

(2015) Lucia Carulli et al.   HEPATOLOGY

Ursodeoxycholic acid exerts farnesoid X receptor-antagonistic effects on bile acid and lipid metabolism in morbid obesity

(2015) Michaela Mueller et al.   JOURNAL OF HEPATOLOGY

The CREB coactivator CRTC2 controls hepatic lipid metabolism by regulating SREBP1

(2015) Jinbo Han et al.   NATURE

Protective effect of ursodeoxycholic acid, resveratrol, andN-acetylcysteine on nonalcoholic fatty liver disease in rats

(2015) Mahmoud Hussein Hassan Ali et al.   PHARMACEUTICAL BIOLOGY

Role of farnesoid X receptor and bile acids in alcoholic liver disease

(2015) Sharon Manley et al.   Acta Pharmaceutica Sinica B

Lipid metabolism and cancer

(2013) Jennifer Glaysher   CURRENT OPINION IN LIPIDOLOGY

Involvement of free radicals and oxidative stress in NAFLD/NASH

(2013) Y. Sumida et al.   FREE RADICAL RESEARCH

Ursodeoxycholic Acid Inhibits Liver X Receptor α-mediated Hepatic Lipogenesis via Induction of the Nuclear Corepressor SMILE

(2013) Ji-Min Lee et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Connecting mTORC1 signaling to SREBP-1 activation

(2012) Inan Bakan et al.   CURRENT OPINION IN LIPIDOLOGY

Pro-apoptotic role of the MEK/ERK pathway in ursodeoxycholic acid-induced apoptosis in SNU601 gastric cancer cells

(2012) SUNG-CHUL LIM et al.   ONCOLOGY REPORTS

Akt Stimulates Hepatic SREBP1c and Lipogenesis through Parallel mTORC1-Dependent and Independent Pathways

(2011) Jessica L. Yecies et al.   Cell Metabolism

A randomized controlled trial of high-dose ursodesoxycholic acid for nonalcoholic steatohepatitis

(2010) Vlad Ratziu et al.   JOURNAL OF HEPATOLOGY

Ursodeoxycholic acid induces glutathione synthesis through activation of PI3K/Akt pathway in HepG2 cells

(2008) Sakiko Arisawa et al.   BIOCHEMICAL PHARMACOLOGY